Key Takeaways
- Ricoh USA has sold its 3D for Healthcare division to Gary Turner, the former VP and GM of Additive Manufacturing at Ricoh USA
- The division has been rebranded as Myrava and will continue to focus on patient-specific anatomical models and point-of-care services
- Myrava has a diverse range of FDA clearances and a strong presence in medical innovation hubs, including a partnership with North Carolina State University
- The medical industry remains a highly valuable market segment for additive manufacturing, with a persistent demand for patient-specific solutions
Introduction to Myrava
Myrava, formerly Ricoh 3D for Healthcare, is a leading provider of patient-specific anatomical models and point-of-care services. The company was spun out of Ricoh USA and acquired by Gary Turner, who previously led the Additive Manufacturing division at Ricoh USA. With a strong focus on medical innovation and a diverse range of FDA clearances, Myrava is well-positioned to meet the growing demand for patient-specific solutions.
Comparison of Myrava and Ricoh 3D for Healthcare
| Feature | Myrava | Ricoh 3D for Healthcare |
|---|---|---|
| Ownership | Gary Turner | Ricoh USA |
| Branding | Myrava | Ricoh 3D for Healthcare |
| Focus | Patient-specific anatomical models and point-of-care services | Patient-specific anatomical models and point-of-care services |
| FDA Clearances | Diverse range of clearances | Diverse range of clearances |
| Partnerships | North Carolina State University | North Carolina State University |
Market Outlook
The medical industry remains a highly valuable market segment for additive manufacturing, with a persistent demand for patient-specific solutions. The US market, in particular, is expected to drive growth, with the medical technology sector valued at over $180 billion. Myrava is well-positioned to capitalize on this trend, with its strong focus on patient-specific anatomical models and point-of-care services.
Bottom Line
The sale of Ricoh 3D for Healthcare to Gary Turner and the subsequent rebranding as Myrava marks an exciting new chapter for the company. With its strong focus on patient-specific anatomical models and point-of-care services, Myrava is poised to meet the growing demand for personalized medical solutions. As the medical industry continues to drive growth in the additive manufacturing sector, Myrava is well-positioned to capitalize on this trend and establish itself as a leader in the market.